{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Rebif (interferon beta-1a) is a prescription medication manufactured by EMD Serono, Inc., used to treat relapsing forms of multiple sclerosis (MS). It comes in prefilled syringes for subcutaneous injection in strengths of 22 mcg/0.5 mL and 44 mcg/0.5 mL. Approved in 2002 under BLA103780, it belongs to the interferon beta class of drugs. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Interferon beta-1a \u2014 ANDA 103628 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628", "mediaType": "text/html", "title": "Interferon beta-1a"}], "identifier": "ANDA103628", "issued": "2016-09-16", "keyword": ["drug", "fda", "health-care", "medications", "prescription-drugs"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Interferon beta-1a"}